Android Apple

EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug

By Yahoo! Finance   |   1 month ago
EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug

The European Commission fined Teva over $500 million for manipulating patents and discrediting a rival's drug. Teva's actions hindered competition and cost countries significant savings. Teva was also fined in the U.S. for price fixing.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.